FLEX vs GILD · P/E 23, rev $6.40B vs P/E 18, rev $29.44B
Flex Ltd (FLEX) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Flex Ltd (FLEX) is a electronic components company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported FLEX revenue for 2025-03-31 was $6.40B. Net income was $838.0M. Revenue was down 2.4% from 2024-12-31 to 2025-03-31. FLEX currently screens at market cap $18.12B and trailing P/E 23.0.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
FLEX currently screens at market cap $18.12B and trailing P/E 23.0. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the FLEX and GILD stock pages for the full models.
Not investment advice.